WEST CHESTER, Pa., March 2, 2023 /PRNewswire/ — Centinel Spine®, LLC, (“the Company”) a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced significant expansion to patient access for the prodisc® L Lumbar Total Disc Replacement (TDR) system. An additional 22 million lives will now be covered as the result of an update to medical necessity guidelines by Aetna® to include a positive coverage policy recommendation for one-level lumbar TDR.
Aetna is one of the largest commercial insurers in the U.S. and previously had a coverage policy that considered one-level lumbar TDR “experimental and investigational” and thus not covered. The new positive coverage policy opens access to patients suffering from one-level symptomatic degenerative disc disease (DDD) who may benefit from total disc replacement using a technology such as prodisc L. With Aetna’s coverage update, all major commercial payors now cover one-level lumbar TDR.
“This announcement reaffirms the strong clinical and radiographic outcomes found in patients implanted with lumbar total disc replacements,” stated Jack Zigler, MD, Texas Back Institute. Dr. Zigler and his partners have implanted over 3,000 lumbar TDRs since the year 2000, with overall excellent clinical results. Continuing, Dr. Zigler commented, “Backed by layers of published Level I data demonstrating the long-term effectiveness of lumbar TDR over the last 23 years, lumbar TDR has some of the most compelling clinical evidence of any technology that is used to improve the quality of patients’ lives.”
“This is outstanding news for patients,” noted Centinel Spine CEO Steve Murray. “In addition to allowing the prodisc LLumbar TDR system to be available to as many as 22 million new patients, this update means that all major U.S. payors now cover this technology for one level. Commercial coverage for one-level lumbar TDR has significantly expanded in recent years and the Aetna decision brings the total amount of covered lives in the US to over 95%. This coverage expansion represents not only an excellent opportunity for surgeons to provide more patients with a broader spectrum of treatment options, but to ensure that patients have access to the best spine care possible.”
In addition to expanded one-level lumbar TDR coverage, patient access and treatment with the prodisc L Lumbar TDR system continues to advance in additional areas. Effective January 1, 2023, providers began to utilize a new Current Procedural Terminology (CPT®) code when performing two-level lumbar total disc arthroplasty via an anterior approach. Centinel Spine’s prodisc L is the only FDA-approved TDR system in the U.S. for two-level use in the lumbar spine. The Company has also recently launched prodisc L Anatomic Endplates—designed to shift the lordotic angle of the lumbar implant to the inferior endplate.
About Centinel Spine, LLC
Centinel Spine®, LLC is a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access. The company offers a continuum of trusted, brand-name, motion-preserving and fusion solutions backed by over 30 years of clinical success—providing the most robust and clinically-proven technology platforms in the world for total disc replacement (prodisc®) and Integrated Interbody™ fusion (STALIF®).
Centinel Spine continues to advance its pioneering culture and corporate mission to become a catalyst of change in the spine industry and alter the way spine surgery is perceived. Centinel Spine remains the only company with comprehensive motion-preserving and fusion solutions for both cervical and lumbar anterior column reconstruction.
For more information, please visit the company’s website at www.CentinelSpine.com or contact:
Centinel Spine
Varun Gandhi
Chief Financial Officer
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8871
Email: [email protected]
Media
Kyle Evans
ICR Westwicke
Phone: 646-677-1295
Email: [email protected]
SOURCE Centinel Spine, LLC